Medicare Materials

Your Results

• KFF Health News: Lack of Affordability Tops Older Americans’ List of Health Care Worries

  July 11, 2024: What weighs most heavily on older adults’ minds when it comes to health care? The cost of services and therapies, and their ability to pay. “It’s on our minds a whole lot because of our age and because everything keeps Read More >

• New Retiree Voting Record Report Released

  February 17, 2022: Scores Congress on Votes Cast during Pandemic’s Second Year Washington, DC – The Alliance for Retired Americans released its 2021 Congressional Voting Record, which scored each U.S. Senator and Representative on critical re Read More >

• HISTORIC VOTE: U.S. House Passes Build Back Better Act to Lower Health Care and Energy Costs, Create Jobs, Cut Pollution that Causes Climate Change

  November 19, 2021: Dora Vasquez, Executive Director of the Arizona Alliance for Retired Americans, issued the following statement after the U.S. House passed President Biden’s Build Back Better Act (BBB), sending the sweeping health care, jobs and Read More >

• Arizona Retirees Cheer House Action to Lower the Price of Health Care, Prescription Drugs, and Create Good Paying Jobs

  November 19, 2021: Saundra Cole, President of the Arizona Alliance for Retired Americans, issued the following statement regarding the U.S. House passage of the Build Back Better Act: (Phoenix) — “House Speaker Nancy Pelosi and Reps. Gallego, Read More >

• Retirees Applaud House Passage of Build Back Better Act that Lowers Drug Costs, Funds Home Care, Adds Guaranteed Hearing Benefit to Medicare

  November 19, 2021: Statement by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding passage of President Biden’s Build Back Better Act, H.R. 5376, in the U.S. House: “The Alliance for Retired Americans applauds Read More >

• KHN: Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets

  January 07, 2021: Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations. Clark, 57, a former insurance agent Read More >